Company · CIK 0001360886 · SIC 2836 — Biological Products, (No Diagnostic Substances)
OSIRIS THERAPEUTICS, INC. · OSIR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 24, 2018 JForm 4 → | Jul 25, 4:20 pm EDT | VENTURETEC INCOther | 3,000,000 | — | — | 0 | — | plan? |
| Jul 5, 2018 JForm 4 → | Jul 9, 4:21 pm EDT | VENTURETEC INC10% Owner | 1,103,301 | — | — | 3,000,000 | — | plan? |
| Jan 25, 2017 MForm 4 → | Jan 26, 4:21 pm EST | David A DresnerInterim President & CEO | 15,000 | $5.30 | $79,500 | 25,000 | — | plan? |
| Jan 23, 2017 MForm 4 → | Jan 24, 4:07 pm EST | David A DresnerInterim President & CEO | 5,000 | $5.03 | $25,150 | 10,000 | — | plan? |
| Jan 12, 2017 MForm 4 → | Jan 17, 8:55 pm EST | David A DresnerInterim President & CEO | 5,000 | $4.75 | $23,750 | 5,000 | — | plan? |
| Nov 20, 2015 MForm 4 → | Nov 20, 5:48 pm EST | Lode DebrabanderePresident & CEO | 37,500 | $6.84 | $256,500 | 37,500 | — | plan? |
| Nov 19, 2015 MForm 4 → | Nov 20, 5:47 pm EST | Alla DanilkovitchChief Scientific Officer | 4,000 | $5.08 | $20,320 | 11,950 | — | plan? |
| Aug 10, 2015 SForm 4 → | Aug 11, 6:32 am EDT | Alla DanilkovitchChief Scientific Officer | 2,425 | $18.22 | $44,184 | 7,950 | −23.4% | plan? |
| Aug 10, 2015 MForm 4 → | Aug 11, 6:32 am EDT | Alla DanilkovitchChief Scientific Officer | 5,000 | $0.40 | $2,000 | 10,375 | — | plan? |
| Jun 4, 2015 PForm 4 → | Jun 8, 4:01 pm EDT | Gregory Ivan LawPrincipal Accounting Officer | 100 | $18.83 | $1,883 | 100 | — | plan? |
| May 27, 2015 SForm 4 → | May 29, 4:30 pm EDT | Philip R Jacoby Jr.Chief Financial Officer | 20,000 | $18.55 | $371,080 | 12,500 | −61.5% | plan? |
| May 27, 2015 MForm 4 → | May 29, 4:30 pm EDT | Philip R Jacoby Jr.Chief Financial Officer | 20,000 | $7.35 | $147,034 | 32,500 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2018 AForm 4 → | Jun 28, 4:10 pm EDT | Jason KeeferInterim President and CEO | 20,000 | — | — | 36,000 | — | |
| Mar 6, 2018 AForm 4 → | Mar 8, 10:33 am EST | Shauna L VernalChief Legal Officer | 20,000 | — | — | 20,000 | — | |
| Mar 6, 2018 AForm 4 → | Mar 8, 10:33 am EST | Linda L ChangChief Financial Officer | 10,000 | — | — | 30,000 | — | |
| Feb 26, 2018 AForm 4 → | Feb 28, 10:34 am EST | Linda L ChangChief Financial Officer | 20,000 | $8.92 | $178,400 | 20,000 | — | |
| Jul 19, 2017 AForm 4 → | Sep 28, 5:14 pm EDT | Alla DanilkovitchChief Scientific Officer | 50,000 | $6.80 | $340,000 | 139,000 | — | late |
| Jul 10, 2017 AForm 4 → | Sep 21, 3:54 pm EDT | Linda PalczukPresident & CEO | 25,000 | $6.67 | $166,750 | 25,000 | — | late |
| Jan 27, 2017 DForm 4 → | Jan 31, 5:07 pm EST | Rodrigo Alberto AvendanoChief Medical Officer | 20,000 | $4.96 | $99,200 | 0 | — | |
| Jan 23, 2017 MForm 4 → | Jan 24, 4:07 pm EST | David A DresnerInterim President & CEO | 5,000 | $5.03 | $25,150 | 15,000 | — | |
| Jan 12, 2017 MForm 4 → | Jan 17, 8:55 pm EST | David A DresnerInterim President & CEO | 5,000 | $4.75 | $23,750 | 20,000 | — | |
| Oct 10, 2016 AForm 4 → | Oct 11, 5:24 pm EDT | David A DresnerInterim President & CEO | 5,000 | $4.75 | $23,750 | 25,000 | — | |
| Sep 12, 2016 AForm 4 → | Sep 12, 4:54 pm EDT | David A DresnerInterim President & CEO | 5,000 | $5.30 | $26,500 | 20,000 | — | |
| Aug 10, 2016 AForm 4 → | Aug 10, 4:55 pm EDT | David A DresnerInterim President & CEO | 5,000 | $5.48 | $27,400 | 15,000 | — | |
| Jul 10, 2016 AForm 4 → | Jul 11, 5:37 pm EDT | David A DresnerInterim President & CEO | 5,000 | $5.03 | $25,150 | 10,000 | — | |
| Jun 9, 2016 DForm 4 → | Jun 13, 5:20 pm EDT | Bobby Dwayne MontgomeryChief Executive Officer, Director | 31,875 | $12.59 | $401,275 | 15,625 | — | |
| Apr 12, 2016 DForm 4/A → | Apr 15, 7:43 am EDT | Jonathan Mark HopperChief Medical Officer | 18,750 | $13.12 | $246,000 | 6,250 | — | |
| Apr 12, 2016 DForm 4 → | Apr 14, 8:50 pm EDT | Jonathan Mark HopperChief Medical Officer | 18,750 | $13.12 | $246,000 | 6,250 | — | amended |
| Mar 9, 2016 DForm 4 → | Mar 14, 6:53 am EDT | Frank D Czworka Jr.Vice President | 50,000 | $15.07 | $753,250 | 53,750 | — | late |
| Mar 4, 2016 AForm 4/A → | Mar 14, 6:53 am EDT | Bobby Dwayne MontgomeryChief Executive Officer, Director | 10,000 | $7.39 | $73,900 | 47,500 | — | |
| Mar 4, 2016 AForm 4 → | Mar 7, 8:16 pm EST | Bobby Dwayne MontgomeryChief Executive Officer, Director | 10,000 | $7.39 | $73,900 | 47,500 | — | amended |
| Feb 22, 2016 DForm 4 → | Feb 24, 8:52 pm EST | Lode DebrabanderePresident & CEO | 163,750 | $15.81 | $2,589,475 | 246,250 | — | |
| Jan 25, 2016 MForm 4 → | Jan 26, 2017, 4:21 pm EST | David A DresnerInterim President & CEO | 15,000 | $5.30 | $79,500 | 0 | — | late |
| Jan 8, 2016 DForm 4 → | Jan 8, 8:05 pm EST | Philip R Jacoby Jr.Principal Accounting Officer | 15,000 | $6.85 | $102,700 | 44,181 | — | |
| Nov 20, 2015 MForm 4 → | Nov 20, 5:48 pm EST | Lode DebrabanderePresident & CEO | 37,500 | $6.84 | $256,500 | 410,000 | — | |
| Nov 19, 2015 MForm 4 → | Nov 20, 5:47 pm EST | Alla DanilkovitchChief Scientific Officer | 4,000 | $5.08 | $20,320 | 89,000 | — | |
| Aug 10, 2015 MForm 4 → | Aug 11, 6:32 am EDT | Alla DanilkovitchChief Scientific Officer | 5,000 | $0.40 | $2,000 | 93,000 | — | |
| May 27, 2015 MForm 4 → | May 29, 4:30 pm EDT | Philip R Jacoby Jr.Chief Financial Officer | 20,000 | $7.35 | $147,034 | 59,181 | — | |
| Mar 6, 2015 AForm 4 → | Mar 9, 4:00 pm EDT | Frank D Czworka Jr.Vice President | 25,000 | $18.40 | $460,000 | 103,750 | — | |
| Mar 6, 2015 AForm 4 → | Mar 9, 4:00 pm EDT | Lode DebrabanderePresident & CEO | 75,000 | $18.40 | $1,380,000 | 447,500 | — |